Brainshuttle

Brainshuttle or brain shuttle is a technology developed to help molecules such as monoclonal antibodies to cross the blood-brain barrier more than they would otherwise. It has been tested with anti-amyloid monoclonal antibodies such as gantenerumab and trontinemab.